Home

Bliss Gvs Pharma Ltd EPS

Image

Bliss GVS Pharma Ltd

NSE: BLISSGVS

EPS

₹ 7.63

Last updated on: Mar 28, 2025

Key Highlights

  • The Earning per Share of Bliss GVS Pharma Ltd is ₹ 7.63 as of 28 Mar 25 .
  • The earning per share of Bliss GVS Pharma Ltd changed from ₹ 1.41 to ₹ 2.27 over 7 quarters. This represents a CAGR of 31.27% .

Historical Earning per Share of Bliss GVS Pharma Ltd

No data available

* All values are in

Company Fundamentals for Bliss GVS Pharma Ltd

Market Cap

1,238 Cr

EPS

7.6

P/E Ratio (TTM)

15.4

P/B Ratio (TTM)

1.2

Day’s High

122.75

Day’s Low

116.15

DTE

0.1

ROE

8.3

52 Week High

184.95

52 Week Low

92.25

ROCE

12.7

Market Price of Bliss GVS Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Bliss GVS Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
28 Mar 2025117.55
27 Mar 2025119.4
26 Mar 2025121.1
25 Mar 2025124.2
24 Mar 2025122.85
21 Mar 2025122.8
20 Mar 2025120.85
19 Mar 2025119.9
18 Mar 2025117.6
17 Mar 2025112.5

SWOT Analysis Of Bliss GVS Pharma Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Bliss GVS Pharma Ltd

Asset Value vs Market Value of Bliss GVS Pharma Ltd

Market Value

1,239

Asset Value

Value addition

0.5 X

835

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Bliss GVS Pharma Ltd1238
Sun Pharmaceutical Industries Ltd416393
Divis Laboratories Ltd153258
Cipla Ltd116434
Torrent Pharmaceuticals Ltd109469
Mankind Pharma Ltd99974

Historical Market Cap of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Bliss GVS Pharma Ltd News Hub

Bliss GVS Pharma to table results

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 October 2024. Po

Read more

18 Oct 24

Bliss GVS Pharma consolidated net profit declines 42.66% in the September 2024 quarter

Net profit of Bliss GVS Pharma declined 42.66% to Rs 24.26 crore in the quarter ended September 2024

Read more

25 Oct 24

Bliss GVS Pharma allots 1.57 lakh equity shares under ESOP

Bliss GVS Pharma has allotted 157,550 equity shares under ESOP on 04 October 2024. With this allotme

Read more

04 Oct 24

Bliss GVS Pharma schedules board meeting

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2025. Po

Read more

22 Jan 25

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Bliss GVS Pharma Ltd

What is the EPS of Bliss GVS Pharma Ltd stock?

The Earnings Per Share (EPS) of Bliss GVS Pharma Ltd is 7.63. An EPS is the amount of net income attributed to each share of a common stock.

How is Bliss GVS Pharma Ltd EPS calculated?

The EPS of Bliss GVS Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Bliss GVS Pharma Ltd report its EPS?

Bliss GVS Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Bliss GVS Pharma Ltd EPS?

Factors that influence the EPS of Bliss GVS Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Bliss GVS Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Bliss GVS Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions